For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Repeal of smokefree laws is set to preserve inequities
Repeal of smokefree laws is set to preserve inequities

This article looks at the detrimental effects that repealing smokefree legislation will have on the head and neck cancer landscape
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Te Whatu Ora. Cancer web tool. December 2023.
2. Dal Maso L, Torelli N, Biancotto E, et al. Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur J Epidemiol 2016;31(4):385–93.
3. Caini S, Del Riccio M, Vettori V, et al. Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis. Br J Cancer 2022;127(11):1907–15.
4. Soeberg M, Blakely T, Sarfati D, et al. Cancer Trends: Trends in cancer survival by ethnic and socioeconomic group, New Zealand 1991–2004. Wellington, NZ: University of Otago and Ministry of Health; 2012.
5. Gurney J, Stanley J, Jackson C, Sarfati D. Stage at diagnosis for Māori cancer patients: disparities, similarities and data limitations. N Z Med J 2020;133(1508):43–64.
6. Ministry of Health. New Zealand Health Survey Annual Data Explorer. December 2023.